During the last four months, Tabuk had received registration approvals for seventeen (17) products in different therapeutic categories in the different MENA countries. The categories targeted included cardiovascular, anti-infective, antifungal, disinfectant, multivitamin, ulcer-healing products, osteoporosis, bone pain related products CNS and analgesics categories.